Dr. Akash Tiwari

Professional Qualification

• MBBS-2011
• MD-2015(Medicine)
• DM-2018 (Medical Oncology)

Area of Expertise

• Treatment of cancer with chemotherapy, immunotherapy and targeted medicine.

Membership

• European Society for Medical Oncology (ESMO)
• Pediatric Hemato-Oncology chapter, Indian Academy of Pediatrics (PHO-IAP)
• The AIIMSONIANS – Alumni association of the All India Institute of Medical Sciences, New Delhi
• ASCO

Conference and workshops

• Invited as speaker to present an abstract at ‘Best of ASCO 2018’ held in July 2018 in New Delhi
• Presented a case discussion at GI preceptorship – “A case of recurrent Ca Rectum with rheumatic heart disease” held in Singapore (November, 2017)
• Participated in GI preceptorship organized by ESMO in Singapore (14th – 16th November)
• Attended UAE cancer congress held in Dubai (5th – 7th October 2017)
• Won Oncology Quiz conducted during ‘3rd MAX debates in oncology’ conducted on 27th August 2017
• Presented Poster ‘clinico-pathologic characteristics of soft tissue sarcoma- A retrospective study from North India’ in ‘Best of ASCO-2017’ in Chandigarh July 2017
• Presented institute’s data on non-metastatic Osteosarcoma in ‘Osteosarcoma update 2016’ organized by Rajeev Gandhi Cancer Institute New Delhi India
• Invited as speaker at 5th National conference on Teen Young Adults Cancer – 17 September 2016, Indore, India

Publications

• Publications in Peer-reviewed Journals (Full Articles)
• Kumar L, Ramavath D, Kataria B, Tiwari A, Raj A, Chellapuram SK, Mookerjee A, Sahoo RK, Malik PS, Sharma A, Gupta R, Sharma OD, Biswas A, Kumar R, Thulkar S; for AIIMS Myeloma Group. High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome. Indian J Med Res. 2019 Jun;149(6):730-739.
• Patel A, Tiwari A, Biswas B, Chand Sharma M, Vishnubhatla S, Bakhshi S.Clinical Predictors and Prognostic Model for Pediatric Lymphoblastic Lymphoma Treated With Uniform BFM90 Protocol: A Single-Center Experience of 65 Patients From Asia. Clin Lymphoma Myeloma Leuk. 2019 Feb 8. pii: S2152-2650(18)31346-6.
• Bhethanabhotla S, Tiwari A, Sharma MC, Vishnubhatla S, Bakhshi S. Prognostic Significance of IL-6 in Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4.
• Gogia A, Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A. Clinicopathological profile of breast cancer: An institutional experience. Indian J Cancer. 2018 Jul-Sep;55(3):210-213
• Tiwari A, Kumar L. Pancreatic ductal adenocarcinoma: Role of chemotherapy & future perspectives. Indian J Med Res. 2018 Sep;148(3):254-257.
• Patekar M, Gogia A, Tiwari A, Kumar L, Sharma A, Mallick SR, Sharma MC, Thulkar S, Gupta R. Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol. South Asian J Cancer. 2018 Jul-Sep;7(3):195-199
• Gogia A, Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, Mallick S. Diffuse large B-cell lymphoma: An institutional analysis. South Asian J Cancer. 2018 Jul-Sep;7(3):200-202
• Tiwari A, Gogia A, Deo S, Shukla NK, Mathur S, Sharma DN. Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience. Indian J Cancer. 2017 Jan-Mar;54(1):343-346
• Rastogi S, Aggarwal A, Tiwari A, Sharma V. Chemotherapy in Nonmetastatic Osteosarcoma: Recent Advances and Implications for Developing Countries. J Glob Oncol. 2017 Jan 18;JGO.2016.007336
• Tiwari A, Gupta V. G., & Bakhshi, S. (2017). Newer medical therapies for metastatic soft tissue sarcoma. Expert Review of Anticancer Therapy,17(3), 257-270.
• Tiwari A, Bakhshi S. Editorial: Indian Guidelines for Treatment of Pediatric

Malignancies. Indian J Pediatr. 2017 May;84(5):369-370

• Nataraj V, Tiwari A, Mathur N, Rani L, Gupta R, Mallick S, Sharma MC, Bakhshi

S. Vascular endothelial growth factor expression in pediatric non-Hodgkin
lymphoma: A prospective study. Pediatr Hematol Oncol. 2016 Apr;33(3):168-70

Other Achievements

• Dr. Akash Tiwari is an alumnus of the prestigious All India Institute of Medical Sciences for the past thirteen years where he pursued his MBBS, MD Medicine, D.M. Medical Oncology. He has published 12 articles in various national and international journals. He specializes in treatment of cancer with chemotherapy, immunotherapy and targeted medicine.
• Awarded Dr. Shakuntala jolly gold medal – 2019 in Medical Oncology for best DM student